Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post 5 Biggest Blockchain ETFs in 2025 next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Editor’s Picks: Gold Tariff Threat Ends, Price Reacts... August 16, 2025 Editor’s Picks: Gold Price Sets Sights on US$3,900,... October 4, 2025 Crypto Market Update: Ripple Raises US$500 Million, Canada... November 7, 2025 Metals Focus: Bullish on Platinum, Bearish on Palladium... October 29, 2025 Lode Gold Closes $1.51 Million Upsized Private Placement September 6, 2025 Craig Hemke: Silver, Gold’s “Outstanding” Year — Will... December 25, 2025 Crypto Market Recap: SEC Issues Crypto ETF Guidance,... July 8, 2025 Chen Lin: Key Silver Date to Watch, My... March 6, 2026 Galan Lithium Limited: SUCCESSFUL DUE DILIGENCE COMPLETED –... August 25, 2025 Guide to Uranium Mining in Canada August 21, 2025